# Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer

> **NCT00004154** · PHASE3 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 111 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** Fenretinide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00004154
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07-30
- **Primary completion:** 2005-03-01
- **Final completion:** 2005-03-01
- **Target enrollment:** 111 (ACTUAL)
- **Last updated:** 2018-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004154, "Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00004154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*